Our first issue of 2022 is live! 🎉

Featuring trials in & a study on in a review on drug-drug interactions between targeted therapies & antifungals, and more! https://t.co/ncz5PtUKup

20 80

Our March issue is out! Featuring articles on outcomes in recipients, the low-PV trial, excess risk of infection with therapy, and more! ➡️https://t.co/EyrqUdHpyd

15 43